1RT

NUFORMIX PLC LS -001

Healthcare · EUR · F

1RT

Price

€0

-100.00%

Cap

€4.44M

Earnings

30d Trend

-100.0%

1RT
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

114% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality31
Momentum58
Technical41
Fundamentals20

Raw weighted: 39×Macro 0.99 (1%)=39

RISK

85/100
90d Volatility
113.7%High
ATR %
12.1%High daily moves
Max Drawdown (1Y)
-66.0%Volatile

QUALITY

31/100
ROE (avg)
-86.4%*Negative
Piotroski F-Score
4/9Average
Accruals
-0.0%Cash earnings

MOMENTUM

58/100
12-1M Momentum
+48.8%Strong uptrend
6-1M Momentum
-31.7%Negative
1M Return
-8.3%Recent pullback

TECHNICAL

41/100
RSI (14)
41.7Neutral
Price vs SMA200
-25.0%Bearish trend
MACD
0.00Bearish momentum
Bollinger Band
30%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.182Noisy/choppy

FUNDAMENTALS

20/100
Shareholder Yield
0.0%Low

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months41
3-12 months31
1-5+ years33

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate NUFORMIX PLC LS -001 at 39/100 — a WEAK reading on the Brain47 Signal. The strongest factor is momentum at 58/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-8.3%

3 MONTHS

-31.2%

12 MONTHS

+40.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Momentum (58) and Technical (41) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 114%. I classify this as a speculative position — elevated volatility at 114% and smaller market cap define the opportunity.

speculativeScore: 39/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.